Paratek Pharmaceuticals Competitors and Similar CompaniesClear all
Paratek Pharmaceuticals's competitors and similar companies include Keros Therapeutics.
 Paratek Pharmaceuticals Paratek Pharmaceuticals is focused on the discovery, development, and commercialization of medicines designed to save lives and alleviate suffering. |  Keros Therapeutics Keros Therapeutics is a biotechnology company that develops therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta. | |
Founding Date | Founding Date 1996 | Founding Date 2015 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Boston, US HQ King Of Prussia, US | Locations Lexington, US HQ South Wharf, AU |
Employees | Employees 10123% increase | Employees 7854% decrease |
Valuation ($) | Valuation ($) 127.8 m | Valuation ($) 2.3 b |
Financial | ||
Revenue (est.) | Revenue (est.) $160.3m (FY, 2022) | Revenue (est.) $244.1m (FY, 2025) |
Net income | Net income ($63.6m) (FY, 2022) | Net income $87m (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 93m | Total funding raised $ 90m |
For sources of this data, please see the company profile
View Company Profiles
Keros Therapeutics
HQ
Lexington, US
Employees
78
Keros Therapeutics is a biotechnology company that develops therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta.
View company